UBS Group AG Has $10.41 Million Stake in Hawkins, Inc. $HWKN

UBS Group AG boosted its position in shares of Hawkins, Inc. (NASDAQ:HWKN) by 49.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 73,274 shares of the specialty chemicals company’s stock after acquiring an additional 24,224 shares during the period. UBS Group AG owned 0.35% of Hawkins worth $10,409,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. First Horizon Corp acquired a new position in Hawkins during the 3rd quarter worth $34,000. Sound Income Strategies LLC acquired a new position in Hawkins during the 4th quarter worth $34,000. Aster Capital Management DIFC Ltd lifted its position in Hawkins by 62.2% during the 3rd quarter. Aster Capital Management DIFC Ltd now owns 300 shares of the specialty chemicals company’s stock worth $55,000 after acquiring an additional 115 shares during the last quarter. Parkside Financial Bank & Trust lifted its position in Hawkins by 694.1% during the 3rd quarter. Parkside Financial Bank & Trust now owns 405 shares of the specialty chemicals company’s stock worth $74,000 after acquiring an additional 354 shares during the last quarter. Finally, Advisory Services Network LLC acquired a new position in Hawkins during the 3rd quarter worth $79,000. Institutional investors and hedge funds own 69.71% of the company’s stock.

Hawkins News Roundup

Here are the key news stories impacting Hawkins this week:

• Positive Sentiment: Sidoti raised Hawkins’ FY2028 EPS estimate to $5.35 from $5.10, signaling stronger expected long-term profitability.
• Positive Sentiment: The firm also increased several 2028 quarterly estimates, including Q1 EPS to $1.55 from $1.52 and Q2 EPS to $1.45 from $1.43, reinforcing a bullish longer-term outlook.
• Neutral Sentiment: Sidoti trimmed some near-term estimates for FY2027 and several 2027 quarters, which tempers the optimism but does not change the broader upward earnings trend.
• Neutral Sentiment: Hawkins recently reported revenue above expectations in its latest quarter, even though EPS came in slightly below consensus, leaving investors with a mixed fundamental picture.

Hawkins Stock Performance

NASDAQ:HWKN opened at $158.98 on Friday. The firm’s 50-day moving average is $153.87 and its 200-day moving average is $146.17. Hawkins, Inc. has a 52-week low of $117.98 and a 52-week high of $186.15. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.46 and a current ratio of 2.21. The company has a market cap of $3.32 billion, a price-to-earnings ratio of 40.66, a PEG ratio of 3.05 and a beta of 0.81.

Hawkins (NASDAQ:HWKN) last posted its quarterly earnings data on Wednesday, May 13th. The specialty chemicals company reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.76 by ($0.02). Hawkins had a return on equity of 16.08% and a net margin of 7.53%.The company had revenue of $265.91 million for the quarter, compared to the consensus estimate of $255.28 million. Equities research analysts anticipate that Hawkins, Inc. will post 4.29 earnings per share for the current year.

Hawkins Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Stockholders of record on Friday, May 29th will be issued a dividend of $0.19 per share. The ex-dividend date is Friday, May 29th. This represents a $0.76 annualized dividend and a dividend yield of 0.5%. Hawkins’s payout ratio is presently 19.44%.

Analysts Set New Price Targets

A number of research analysts have weighed in on HWKN shares. Weiss Ratings raised shares of Hawkins from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday. BWS Financial reissued a “buy” rating and set a $200.00 target price on shares of Hawkins in a research report on Monday, March 23rd. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $200.00.

About Hawkins

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.